Thromboprophylaxis for Children Post-Fontan Procedure: Insights From the UNIVERSE Study.

Autor: McCrindle BW; The Hospital for Sick Children University of Toronto Toronto ON Canada., Michelson AD; Boston Children's HospitalHarvard Medical School Boston MA., Van Bergen AH; Advocate Children's Hospital Oak Lawn IL., Suzana Horowitz E; Institute of Cardiology of Rio Grande do Sul/University Foundation of Cardiology Porto Alegre Brazil., Pablo Sandoval J; National Institute of Cardiology Mexico City Mexico., Justino H; Rady Children's Hospital San Diego CA., Harris KC; Children's Heart CentreBC Children's Hospital Vancouver BC Canada., Jefferies JL; The Cardiac Institute University of Tennessee Health Science Center Memphis TN., Miriam Pina L; Janssen Research and Development, LLC Raritan NJ., Peluso C; Janssen Research and Development, LLC Raritan NJ., Nessel K; Janssen Research and Development, LLC Raritan NJ., Lu W; Janssen Research and Development, LLC Raritan NJ., Li JS; Duke University Medical Center Durham NC.

Publikováno v: Journal of the American Heart Association [J Am Heart Assoc] 2021 Nov 16; Vol. 10 (22), pp. e021765. Date of Electronic Publication: 2021 Sep 24.

Dabigatran for Treatment and Secondary Prevention of Venous Thromboembolism in Pediatric Congenital Heart Disease.

Autor: Albisetti, Manuela, Tartakovsky, Igor, Halton, Jacqueline, Bomgaars, Lisa, Chalmers, Elizabeth, Mitchell, Lesley G., Luciani, Matteo, Nurmeev, Ildar, Gorbatikov, Kirill, Miede, Corinna, Brueckmann, Martina, Brandão, Leonardo R.

Publikováno v: Journal of the American Heart Association; 2/20/2024, Vol. 13 Issue 4, p1-11, 11p